OncoCyte Corporation (OCX)
2.15
0.00 (0.00%)
At close: Jan 15, 2025, 12:36 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -27.78M | -72.90M | -64.10M | -29.93M | -22.43M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.50M |
| Depreciation & Amortization | 1.68M | 5.22M | 4.21M | 1.90M | 351.00K | 559.00K | 580.00K | 387.00K | 283.00K | 281.00K | 277.00K |
| Stock-Based Compensation | 6.57M | 10.04M | 6.84M | 5.07M | 3.00M | 1.48M | 1.63M | 922.00K | 1.81M | 318.00K | 326.00K |
| Other Working Capital | 677.00K | -1.66M | 373.00K | -273.00K | -2.30M | -9.00K | -638.00K | 2.11M | 1.28M | 2.93M | 2.13M |
| Other Non-Cash Items | 174.00K | 14.01M | 28.57M | -2.16M | 437.00K | 118.00K | 83.00K | 1.70M | 18.00K | 291.00K | 326.00K |
| Deferred Income Tax | n/a | n/a | -9.26M | -1.25M | 483.00K | 956.00K | 4.38M | n/a | 65.00K | n/a | -326.00K |
| Change in Working Capital | -3.97M | -1.94M | -2.20M | 399.00K | -1.55M | 993.00K | -686.00K | 2.34M | 2.33M | 3.22M | 2.18M |
| Operating Cash Flow | -23.32M | -45.57M | -35.94M | -25.98M | -19.71M | -11.65M | -13.38M | -7.52M | -4.23M | -1.16M | -710.00K |
| Capital Expenditures | -281.00K | -4.34M | -2.25M | -1.23M | -918.00K | -31.00K | -91.00K | -106.00K | -500.00K | -9.00K | -25.00K |
| Acquisitions | n/a | n/a | -11.71M | -10.51M | -11.24M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -4.00M | -11.24M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 367.00K | n/a | n/a | 4.00M | 11.24M | n/a | 934.00K | n/a | 815.00K | 1.33M | n/a |
| Other Investing Acitivies | -1.02M | -4.34M | -13.35M | -7.00K | -252.00K | -240.00K | 934.00K | -75.00K | 815.00K | 1.33M | n/a |
| Investing Cash Flow | -932.00K | -4.34M | -13.96M | -11.75M | -12.41M | -31.00K | 843.00K | -181.00K | 315.00K | 1.32M | -25.00K |
| Debt Repayment | -117.00K | -1.43M | -1.53M | 695.00K | 1.36M | -1.18M | 1.58M | -114.00K | n/a | n/a | n/a |
| Common Stock Repurchased | -1.12M | n/a | -239.00K | -14.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -96.00K | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.54M | 4.39M | 2.15M | 1.31M | -2.35M | -201.00K | 8.38M | -555.00K | 4.00K | n/a | n/a |
| Financial Cash Flow | 12.19M | 35.81M | 78.36M | 22.80M | 47.87M | 12.11M | 9.97M | 9.88M | 11.65M | n/a | n/a |
| Net Cash Flow | -12.07M | -14.10M | 28.46M | -14.93M | 15.74M | 434.00K | -2.57M | 2.18M | 7.74M | 156.00K | -735.00K |
| Free Cash Flow | -23.61M | -49.91M | -38.19M | -27.21M | -20.63M | -11.68M | -13.48M | -7.63M | -4.73M | -1.17M | -735.00K |